Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Richaaard who wrote (1404)	8/13/1999 7:41:00 AM
From: vestor	Read Replies (2) \| Respond to of 1837

Heard report this morning that Wall St. has begun to wake-up to the drug sector. That sector was the biggest gainer yesterday and I understand also for the past week. Should this be true then thats an added plus especially since new investors that buy stocks in sectors that are leading may discover DRMD. Looking forward there is a good case to argue for the mid 20's by years end and mid 30's by 3/30/2000. From a this yr vs last yr and a this qtr. vs last qtr. the numbers look real good going forward. Wall St. looks ahead not back. A good time to buy may be in the lull between this BC approval and the 1.25 Cenestin dosage expected approval.